Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA1 | P30542 | 7/20 | 0.41 |
| ▸ | ADORA3 | P0DMS8 | 4/20 | 0.41 |
| ▸ | ADORA2A | P29274 | 3/20 | 0.41 |
| ▸ | ADORA2B | P29275 | 2/20 | 0.41 |
| ▸ | SLC29A1 | Q99808 | 2/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | GLA | P06280 | 1/20 | 0.40 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | NPY1R | P25929 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | NPY2R | P49146 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31677375 | 1.00 | ADORA1 (0.41) | ADORA1ADORA3ADORA2AADORA2BSLC29A1 | |
| SCHEMBL7774654 | 0.91 | ADORA1 (0.39) | ADORA1ADORA3ADORA2AADORA2BSLC29A1 | |
| SCHEMBL28023787 | 0.89 | ADORA3 (0.48) | ADORA1ADORA3ADORA2AADORA2BSLC29A1 | |
| SCHEMBL28165438 | 0.81 | ADORA1 (0.45) | ADORA1ADORA3ADORA2AADORA2BSLC29A1 | |
| SCHEMBL30516580 | 0.80 | ADORA3 (0.38) | ADORA1ADORA3ADORA2AADORA2BSLC29A1 | |
| SCHEMBL27518665 | 0.80 | ADORA1 (0.43) | ADORA1ADORA3ADORA2AADORA2BSLC29A1 | |
| SCHEMBL5698887 | 0.79 | ADORA3 (0.51) | ADORA1ADORA3ADORA2AADORA2BSLC29A1 | |
| SCHEMBL7033904 | 0.79 | ADORA3 (0.51) | ADORA1ADORA3ADORA2AADORA2BSLC29A1 | |
| SCHEMBL27456462 | 0.79 | ADORA3 (0.51) | ADORA1ADORA3ADORA2AADORA2BSLC29A1 | |
| SCHEMBL6551165 | 0.79 | ADORA3 (0.51) | ADORA1ADORA3ADORA2AADORA2BSLC29A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-2001517674-A | — | — | 2001-10-09 | — | — | JP | claimed |
| EP-1017703-A2 | PENTOPYRANOSYL NUCLEOSIDE, AND PRODUCTION AND USE OF THE SAME | Nanogen Recognomics GmbH (DE) | 2000-07-12 | — | — | EP | claimed |
| WO-1999015539-A2 | PENTOPYRANOSYL NUCLEOSIDE, AND PRODUCTION AND USE OF THE SAME | AVENTIS RESEARCH & TECHNOLOGIES GMBH & CO. KG (DE) | 1999-04-01 | — | — | WO | claimed |
| US-20040198966-A1 | Pentopyranosylnucleoside, its preparation and use | NANOGEN RECOGNOMICS GMBH | 2004-10-07 | — | — | US | disclosed |
| US-6608186-B1 | Of given formula; use for the production of a therapeutic, diagnostic and/or electronic component; use in the construction of supramolecular units | NANOGEN RECOGNOMICS GMBH (DE) | 2003-08-19 | — | — | US | disclosed |
| EP-1017703-A2 | PENTOPYRANOSYL NUCLEOSIDE, AND PRODUCTION AND USE OF THE SAME | Nanogen Recognomics GmbH (DE) | 2000-07-12 | — | — | EP | disclosed |
| WO-1999015539-A2 | PENTOPYRANOSYL NUCLEOSIDE, AND PRODUCTION AND USE OF THE SAME | AVENTIS RESEARCH & TECHNOLOGIES GMBH & CO. KG (DE) | 1999-04-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040198966-A1 | Pentopyranosylnucleoside, its preparation and use | FUT6, ST3GAL3, FUT5 | ADORA1 817/4885ADORA3 1415/4885ADORA2A 1693/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.